Company intelligence / Profile preview

Golden Throat

Liuzhou, Guangxi Zhuang Autonomous Region, China

Ownership: Private
Development stage: Other

Overview

Golden Throat manufactures and markets a range of over-the-counter lozenges and related pharmaceutical/healthcare food products. Its flagship product, the herbal-based "Golden Throat Lozenges," has been approved for use in China since at least August 2020 for relief of sore/dry throat and hoarseness caused by acute pharyngitis. The company also offers sugar-free variants, probiotic lozenges, intestinal series products, and Yinxingye tablets for blood circulation. Products are exported globally including to the US/EU/Japan/Australia/Southeast Asia/Middle East/Mexico/Africa.

Therapeutic areas: CardiovascularGastroenterologyPulmonologyInfectious Diseases
Modalities: Herbal medicineSmall moleculeProbioticDevice
Industry: Biotech

Beyond the preview

Go deeper on Golden Throat.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Golden Throat.

Explore the full profile